pharma news today obesity drugs glp-1 september 2025 Agonists Market Report 2025-2033, By Product, Molecule, and Geo Some Medicare beneficiaries can now

The combined primary endpoint of death from cardiovascular disease, nonfatal myocardial infarction, or nonfatal stroke occurred in 569 (6.5%) of patients in the semaglutide group versus 701 (8.0%) of patients in the placebo group, yielding a significant hazard ratio of 0.8 for a 20% relative risk reduction

Stabilized 15-residue peptide compound + palmitoylethanolamide

How treatment duration affects total spending Treatment duration determines cost escalation patterns

Its rebate capture , intermediary margin , and contract gaming : the hidden layer of U.S

V l trnh, nn dng theo chu k (v d mt t vi thng ri ngh 12 thng) thay v dng lin tc v thi hn, v nn tham kho dc s/bc s da liu c l trnh ph hp vi c a